WuXi Biologics (Cayman) Inc. (HKG:2269)
48.88
-0.74 (-1.49%)
Nov 11, 2026, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 14,705 employees as of June 30, 2026. The number of employees increased by 1,453 or 10.96% since the number was reported on December 31, 2025. That makes WuXi Biologics the 2,444th largest employer in the world and 210th in Hong Kong.
Employees
14,705
Change
1,453
Growth
10.96%
Revenue / Employee
1.85M HKD
Profits / Employee
393.24K HKD
Market Cap
200.59B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 14,705 | 1,453 | 10.96% |
| Dec 31, 2025 | 13,252 | 677 | 5.38% |
| Dec 31, 2024 | 12,575 | -165 | -1.30% |
| Dec 31, 2023 | 12,740 | 367 | 2.97% |
| Dec 31, 2022 | 12,373 | 2,509 | 25.44% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 22,838 |
| BeOne Medicines AG | 12,000 |
| Innovent Biologics | 8,754 |
| Genscript Biotech | 6,135 |
| 3SBio | 6,068 |
| Akeso | 4,082 |
| Shanghai Henlius Biotech | 4,082 |
| RemeGen | 3,145 |
WuXi Biologics News
- 7 days ago - WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence - PRNewsWire
- 9 days ago - Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline - PRNewsWire
- 9 days ago - Fresenius, WuXi Enter Development Agreement To Expand Biosimilars Pipeline - Nasdaq
- 21 days ago - WuXi Biologics Receives Top-Honor Jade Award at The Asset Corporate Sustainability Leadership Awards 2026 - PRNewsWire
- 27 days ago - WuXi Biologics Continues to Be Included in Multiple Hang Seng Sustainability Indexes, Demonstrating ESG Excellence - PRNewsWire
- 6 weeks ago - WuXi Biologics Passes Another FDA GMP Inspection, Reinforcing Its Quality Track Record and Commercial Supply Reliability - PRNewsWire
- 1 month ago - WuXi Biologics Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership - PRNewsWire
- 1 month ago - Big Pharma Is Pouring Billions Into China's Biotechs - Barrons